Lipocine Inc expected to post a loss of 40 cents a share - Earnings Preview

Lipocine

03/03/2025 13:45

Lipocine Inc LPCN.OQ LPCN.O is expected to show a rise in quarterly revenue when it reports  results on March 5 (estimated) for the period ending December 31 2024

The Salt Lake City Utah-based  company is expected to report a 1,109.1% increase in revenue to $2.614 million from $216.19 thousand a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Lipocine Inc is for a loss of 40 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Lipocine Inc is $10.00​, above​ its last closing price of $3.07. ​​​

This summary was machine generated March 3 at 13:45 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)